News

age related macular degeneration
Possible link between instant coffee and increased risk of developing age-related macular degeneration
A study that was recently published in Food Science & Nutrition reveals that instant coffee drinkers had almost 8 times the increased risk of developing dry age-related macular degeneration.

eye drops
Prescription eye drops recalled
This year has seen several eye drop recalls already and yet another one has been added to this list.
While previous recalls have involved over-the-counter eye drops, the latest recall is for prescr...

diabetes
Popular diabetes and weight loss drug linked to double the risk of developing neovascular macular degeneration
Semaglutide, a popular diabetes and weight loss drug, has been found to double the risk of developing neovascular age-related macular degeneration (nAMD) in older patients with diabetes.

How Lutein and Zeaxanthin Support Long-Term Vision Health
Lutein and zeaxanthin are carotenoids that support the eye's macula by filtering blue light and acting as powerful antioxidants.

Comparing AREDS 2 Eye Vitamins: Zinc-Free and E-Free Options for Personalized Vision Support
AREDS 2 eye supplements are available in specialized formulas, including zinc-free and E-free, to provide tailored antioxidant support for long-term eye health.

dry eye
Tryptyr receives FDA approval as a dry eye disease
Patients suffering from dry eye disease symptoms now have another treatment option.

bevacizumab
HIV drug improves vision for Diabetic Macular Edema patients
Researchers are hopeful that Iamivudine, an inexpensive, oral drug that has been used to treat HIV, may be a cost-effective and non-invasive therapy for patients.

cardiovascular disease
Increased heart disease risk linked with vitamin D deficiency
A recent study published by German researchers highlights the connection between vitamin D and cardiovascular disease.

FDA recalls
Large scale voluntary recall of several eye care products
A Class II risk, which is the second-highest warning rating, was issued by the FDA for five ophthalmic solutions due to violations of current manufacturing practices.